Archives
FDA Approves Drug to Treat Gastrointestinal Stromal Tumors
A new drug Stivarga has won the approval of the U.S. Food and Drug Administration to cure patients who are victims of advanced gastrointestinal stroma tumors (GIST) that cannot be removed surgically and have failed to respond to other FDA-approved treatments.
Latest Research Articles
Four New Species of Rove Beetles Found in China
Severe Frostbite Forces British Explorer to Quit Antarctic Expedition
Vulcan, Cerberus Win Online Poll of Naming Pluto's Moons
India's PSLV-C20 Successfully Launched
Babies Born by C-section More Prone to Developing Allergies, Researchers Say
Ancient Micro-Continent Found Beneath Indian Ocean
World’s Smallest Telescopes to be Launched Monday
Antares Rocket Successfully Passes Engine Test
Natural Antibiotic from Sweat can Fight TB Germs, Bugs: Study
Scientists Predict More Snowfall in Polar Regions, but Less Worldwide
Scientists Develop New Drug against Flu Virus
Space Shuttle Atlantis to be Exhibited this Summer
MOST POPULAR
-
Sunken Worlds in Earth's Mantle: High-Res Models Challenge Current Theories
-
What Caused the Palisades Wildfire Ravaging Homes in the Los Angeles Area?
-
With No Water Coming Out of Fire Hydrants, Can Ocean Water Be Used to Fight Raging LA Fire?
-
230-Million-Year-Old Fossil in Wyoming Redefines Dinosaur Origins
-
Young Boy's Ant Discovery Uncovers Hidden Connection in Nature
